ACSL1 and cancer: Inhibition of MCL-1 results in decreased oxidation of long-chain fatty acids (LCFAs) in cancer cells22,24, likely due to the disrupted interaction between MCL-1 and the BH3-like domain of acyl-CoA synthetase long-chain family member 1 (ACSL-1).